U.S. News & World Report corrects an error that improves Doernbecher Children’s Hospital ranking among U.S. children’s hospitals.

In a story about the upcoming wildfire season, Gopal Allada, M.D., raises concern about lung damage. He says, “Wildfires tend to emit microscopic-sized particles that easily get into the lungs and trigger inflammation.”

Fourth-generation doctor in Idaho credits her medical education at OHSU for its focus on rural medicine and primary care.

News coverage of vaccine developed at OHSU to treat a diarrheal disease that afflicts millions of people in the developing world. Mark Slifka, Ph.D., says, “Campylobacter has been associated with infant growth stunting. Targeting a disease like this can help a lot of people – including kids in developing countries – grow stronger by reducing the damage caused by these bacteria.”

OHSU is awarded five years of funding to establish research hub focused on botanical dietary supplements to lower stress, improve sleep and mood, and stave off cognitive decline in aging.

OHSU evidence review examines whether masks and facial coverings prevent the spread of respiratory illnesses, including COVID-19.

Heidi Nelson, Ph.D., says, “Approximately 40 percent of women are affected by anxiety disorders during their lifetimes, which is twice the rate of men.”

Act of racism discovered at construction site where Portland State University, Portland Community College, the City of Portland and OHSU are building a joint facility.

In a story on mandatory indoor mask requirements, Gopal Allada, M.D., says the smartest and healthiest thing to do is wear a mask, keep physical distancing along with frequent hand washing. “Those are always going to be the trifecta of prevention,” he says.

The Lymphatic Education & Research Network grants OHSU the highest-level designation as a center of excellence in lymphatic disease diagnosis and management. OHSU is one of 11 institutions worldwide providing all services on one campus.